Ling Li

Johns Hopkins University - Division of Gastroenterology and Hepatology

SCHOLARLY PAPERS

1

DOWNLOADS

13

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

A Combination Therapy of Bortezomib, CXCR4 Inhibitor and Checkpoint Inhibitor is Effective in Cholangiocarcinoma in vivo

Number of pages: 27 Posted: 08 Aug 2022
Ling Li, Yang Zhou, Yicheng Zhang, Haijie Hu, Hai-Quan Mao and Florin Selaru
Johns Hopkins University - Division of Gastroenterology and Hepatology, University of Washington, Johns Hopkins University - The Institute for NanoBioTechnology, Johns Hopkins University - Division of Gastroenterology and Hepatology, Johns Hopkins University - The Institute for NanoBioTechnology and Johns Hopkins University - Division of Gastroenterology and Hepatology
Downloads 13 (1,246,774)

Abstract:

Loading...

Cholangiocarcinoma, Organoids, CXCR4 inhibitor, Bortezomib, tumor infiltration Tlymphocyte, anti-PD1, immune therapy